Rui Guo

4PUBLICATIONS
38CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 10, 2026
TQB2618 plus Penpulimab, Alone or in Combination with Chemotherapy, for Recurrent or Metastatic Nasopharyngeal Carcinoma: A Multicenter, Two-Cohort, Phase II Trial.

|Nov 11, 2025
USP18 promotes nasopharyngeal carcinoma radioresistance via TRIM29 oligomerization and ubiquitination.

Jia-Yi Lin, Jun-Xiang Chen, Zi-Chen Qiu

|Feb 19, 2025
Reduced-volume radiotherapy versus conventional-volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open-label, noninferiority, multicenter, randomized phase 3 trial.

Ling-Long Tang, Lin Chen, Gui-Qiong Xu

|Aug 15, 2020
Prognostic value of MRI-determined cervical lymph node size in nasopharyngeal carcinoma.

Cheng-Long Huang, Yang Chen, Rui Guo

Pageof 1

Frequent Collaborators

4 joint publications

Jun Ma

3 joint publications

Ling-Long Tang

2 joint publications

Li-Zhi Liu

2 joint publications

Ying Sun